Evidence map›Paper›PMID 38962000›Full record

ArticlePCN reports : psychiatry and clinical neurosciences2024

Psychological treatments for mental health symptoms associated with COVID-19 infection: A scoping review.

So Sugita, Kotone Hata, Krandhasi Kodaiarasu, Naoki Takamatsu, Kentaro Kimura, Christian Miller, Lecsy Gonzalez, Ikue Umemoto, Keitaro Murayama, Tomohiro Nakao and 3 more

Abstract readScoping Review
In one paragraph

Article in PCN reports : psychiatry and clinical neurosciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

So SugitaNational Center for Cognitive Behavior Therapy and Research National Center of Neurology and Psychiatry Tokyo Japan.ORCID 0000-0002-5624-4552
Kotone HataFaculty of Human Sciences Waseda University Tokyo Japan.
Krandhasi KodaiarasuMcLean Hospital, Simches Division of Child and Adolescent Psychiatry Belmont Massachusetts USA.
Naoki TakamatsuNational Center for Cognitive Behavior Therapy and Research National Center of Neurology and Psychiatry Tokyo Japan.ORCID 0000-0003-1704-6411
Kentaro KimuraNational Center for Cognitive Behavior Therapy and Research National Center of Neurology and Psychiatry Tokyo Japan.
Christian MillerCornell University Ithaca New York USA.
Lecsy GonzalezUniversity of Florida Gainesville Florida USA.
Ikue UmemotoNational Center for Cognitive Behavior Therapy and Research National Center of Neurology and Psychiatry Tokyo Japan.
Keitaro MurayamaDepartment of Neuropsychiatry Kyushu University Hospital Fukuoka Japan.ORCID 0000-0002-3997-6823
Tomohiro NakaoDepartment of Neuropsychiatry, Graduate School of Medical Sciences Kyushu University Fukuoka Japan.
Shinsuke KitoNational Center for Cognitive Behavior Therapy and Research National Center of Neurology and Psychiatry Tokyo Japan.
Masaya ItoNational Center for Cognitive Behavior Therapy and Research National Center of Neurology and Psychiatry Tokyo Japan.
Hironori KugaNational Center for Cognitive Behavior Therapy and Research National Center of Neurology and Psychiatry Tokyo Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this scoping review was to synthesize published studies and ongoing clinical trials of psychological interventions for mental health problems associated with COVID-19 infection. The study protocol was developed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Extension for Scoping Reviews. We conducted systematic searches for studies published or registered between January 2020 and October 2022 using eight scientific databases and clinical trial registries, which identified 40 complete published studies and 53 ongoing clinical trials. We found that most studies were randomized controlled trials (74%) while the remaining used study designs of lower methodological quality. Most studies investigated interventions for acute COVID-19 patients (74%) and others explored post-COVID conditions (PCC) or recovered patients. Cognitive and behavioral therapies were the main intervention approaches (31%), followed by multidisciplinary programs (21%) and mindfulness (17%). The most frequently evaluated outcomes were anxiety (33%), depression (26%), quality of life (13%), and insomnia (10%). No studies on youths, older people, or marginalized communities were found. These findings summarize the burgeoning research on a range of psychological interventions for individuals infected with COVID-19. However, the field is in its infancy and further research to develop an evidence base for targeted care is necessary. The gaps identified in the current study also highlight the need for more research on youths, older people, and members of marginalized communities, and PCC patients. It is important to ascertain interventions and delivery strategies that are not only effective and affordable but also allow high scalability and accessibility.

Indexed as

anxietyCOVID‐19depressionpsychotherapysleep initiation and maintenance disorders

Identifiers

PMID38962000
PMCPMC11216928

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.